Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Brightpoint - CELL -- Ignore unavailable to you. Want to Upgrade?

To: Tom K. who wrote (613)	6/25/1998 5:59:00 PM
From: Paul Shread	Respond to of 1999

Tom, I assume it's going to move up as we get closer to earnings (if they don't warn in the next week or so). Frankly, if CLST can meet estimates, then so can CELL, IMO. Good luck to you. Crap like this is why I've been buying nothing but huge, diversified companies lately. They always seem to bounce back first. ERICY missed earnings estimates last quarter and has since set a new high; CELL blows away earnings and is approaching its 52-week low. Go figure. Paul

To: Tom K. who wrote (613)	6/25/1998 6:44:00 PM
From: Brian Lempel	Read Replies (2) \| Respond to of 1999

Tom and Paul, First, Tom, I would not advise writing calls against CELL. That would be to assume that we will languish at this level. IMO, that is not why you are long the stock in the first place. If you think earnings will not disappoint, then you should just hold the stock or consider buying calls, not selling them. If you do think we will not meet estimates, then by all means get out of here and move into something that will move in the next 3 months! Now I have gone the value approach before. This has landed me in such winners as APM and CREAF. While I felt that I didn't do too much wrong in picking these (just picked a couple losers), CELL is much different. CELL will not have problems meeting growth unless cellular market dries up (unlikely) or carriers go to direct distribution (in which case CELL would make a nice takeover candidate for a catch up player). Now if you look at the numbers, Merrill's $1.10 for next year (only the first round of upward revisions) means a range of $20 to $40 for next year. So why are you worried about us going lower or writing calls to gradually recoup your losses? I am buying more, personally. And to Paul (and I know this post ended up being very long), I reread the ML report from when they thought Nokia was a problem. It didn't really say too much, other than the 5100 series is on location in Europe. It was also rumored a few days before this report that this was the reason for CELL coming off its highs. Other points were that they think that there is upside to their year end estimate of .78 due to positive results from acquisitions. They have a 2-1 rating. Forget their exact term (strong buy or just buy), but 1 is best, and the 2 is short term, 1 is long term. Brian